- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 2 x N2E: ~{N}-[4-fluoranyl-3-[6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]phenyl]-2,4-dimethyl-1,3-oxazole-5-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nagle, A. et al., Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases. J.Med.Chem. (2020)
- Release Date
- 2020-08-26
- Peptides
- Proteasome subunit alpha type: AO
Proteasome subunit alpha type: BP
Proteasome subunit alpha type: CQ
Proteasome endopeptidase complex: DR
Proteasome subunit alpha type: ES
Proteasome subunit alpha type: FT
Proteasome endopeptidase complex: GU
Proteasome subunit beta: HV
Proteasome subunit beta: IW
Proteasome subunit beta: JX
Proteasome subunit family protein: KY
Proteasome subunit beta: LZ
Proteasome subunit beta: M0
Proteasome subunit beta: N1 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AO
aB
BP
bC
CQ
cD
DR
dE
ES
eF
FT
fG
GU
gH
HV
hI
IW
iJ
JX
jK
KY
kL
LZ
lM
M0
mN
N1
n